June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
TIMP3 Aggregates in Endothelial Cells Expressing Sorsby Fundus Dystrophy Associated TIMP3 Mutations is Regulated by Glycosylation.
Author Affiliations & Notes
  • Jian Hua Qi
    Ophthalmic Research-ColeEye Inst, Cole Eye Institute, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Jian Qi, None
  • Footnotes
    Support  FFB Center Grant (BAA) Unrestricted Grant from Research to Prevent Blindness, Inc., New York, NY. NIH-NEI P30 Core Grant (1P30EY025585-01A1) awarded to the Cole Eye Institute
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1935. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jian Hua Qi; TIMP3 Aggregates in Endothelial Cells Expressing Sorsby Fundus Dystrophy Associated TIMP3 Mutations is Regulated by Glycosylation.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1935. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Purpose: Sorsby’s fundus dystrophy (SFD) is an autosomal dominant macular disorder that closely resembles age-related macular degeneration (AMD). SFD is caused by mutations in tissue Inhibitor of metalloproteinase-3 (TIMP3) gene and is of considerable interest due to early onset of choroidal neovascularization (CNV). The objective of this study is to investigate the molecular mechanism(s) by which TIMP3 mutants regulate choroidal neovascularization

Methods : Methods: Porcine aortic endothelial (PAE) cells lines that express wild-type TIMP3, three unique SFD mutant TIMP3 genes (S156C-TIMP3, Y168C-TIMP3 and S181C-TIMP3) and N184Q-SFD-TIMP3 mutants and RPE-choroid tissue from S156C-TIMP3 knock-in mouse and AMD eyes were analyzed for TIMP3 isoforms and VEGF-induced signaling.

Results : Results: During the analysis of these cell lines we determined that compared to wild-type TIMP3 in endothelial cells, mutant TIMP3 was more glycosylated and showed small increases in aggregates. To evaluate if the glycosylation state of TIMP3 contributed to the aggregation of TIMP3 we evaluated double mutant lines with an additional mutation at Asn184 (the only potential N-glycosylation site on TIMP3 [23]). We observed that upon deglycosylation of TIMP3 there was a dramatic increase in high molecular weight species of aggregated mutant TIMP3 (resistant to reducing agents) as well as increased angiogenesis in response to VEGF.

Conclusions : Conclusion: The crosslinking and aggregate formation of mutant TIMP3 is inversely proportional to the glycosylation of TIMP3, which contributes to increased angiogenesis and CNV.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.